| Financier | Commitments |
|---|---|
| International Bank for Reconstruction and Development | 6.00 |
Eswatini COVID-19 Emergency Response Project
Abstract*
The project components are aligned with the objectives of the COVID-19 Strategic Preparedness and Response Program (SPRP), which adopts a multi-phase programmatic approach (MPA). This emergency project comprise 3 components: (i) Emergency COVID-19 Response; (ii) Implementation Management and Monitoring and Evaluation; and (iii) Contingent Emergency Response Component. The components aim to strengthen Eswatini’s health system preparedness to respond... Show More
Development Objective
The Program Development Objective is to prevent, detect and respond to the threat posed by COVID-19 and strengthen national systems for public health preparedness in Eswatini.
Key Details
Project Details
P173883
Closed
Tengetile Tsabedze , Kenneth Kabubei
Kingdom of Eswatini
April 10, 2020
(as of board presentation)
April 20, 2020
April 30, 2020
US$ 6.00 million
Ministry of Health
2020
US$ 6.00 million
N/A
May 6, 2024
September 30, 2024
No
BANK APPROVED
Finances
Financing Plan (US$ Millions)
Total Project Financing (US$ Millions)
| Product Line | IBRD/IDA |
|---|---|
| IBRD Commitment | 6.00 |
| IDA Commitment | N/A |
| IBRD + IDA Commitment | 6.00 |
| Lending Instrument | |
|---|---|
| Grant Amount | N/A |
| Total Project Cost** | 6.00 |
Summary Status of World Bank Financing (US$ Millions) as of March 31, 2025
No data available.
| Period | Financier | Transaction Type | Amount (US$) |
|---|---|---|---|
| Apr 20, 2020 | IBRD-90980 | Loan Commitment | 6,000,000.00 |
| Apr 16, 2021 | IBRD-92310 | Loan Commitment | 5,000,000.00 |
| Feb 15, 2021 | IBRD-90980 | Int Charges | 13,114.37 |
| Aug 15, 2024 | IBRD-90980 | Int Charges | 214,783.75 |
| Aug 15, 2024 | IBRD-90980 | Int Charges | 1,102.68 |
| Feb 15, 2023 | IBRD-90980 | Int Charges | 146,893.34 |
| Aug 21, 2023 | IBRD-90980 | Int Charges | 194,575.00 |
| Aug 15, 2021 | IBRD-90980 | Int Charges | 34,641.51 |
| Aug 24, 2021 | IBRD-90980 | Loan Disb | 628,552.40 |
| Aug 15, 2021 | IBRD-90980 | Int Charges | 472.46 |
| Aug 15, 2022 | IBRD-90980 | Int Charges | 64,556.67 |
| Feb 15, 2022 | IBRD-90980 | Int Charges | 902.63 |
| Feb 15, 2022 | IBRD-90980 | Int Charges | 38,510.58 |
| Dec 3, 2020 | IBRD-90980 | Loan Disb | 394,317.84 |
| Apr 30, 2020 | IBRD-90980 | Loan Disb | 15,000.00 |
| Apr 30, 2020 | IBRD-90980 | Fee Charges | 15,000.00 |
| Jun 30, 2020 | IBRD-90980 | Loan Disb | 3,891,353.00 |
| Jul 17, 2020 | IBRD-90980 | Loan Disb | 262,260.00 |
| Aug 15, 2024 | IBRD-92310 | Int Charges | 11,238.73 |
| Aug 15, 2024 | IBRD-92310 | Int Charges | 528.69 |
| Aug 15, 2024 | IBRD-92310 | Int Charges | 147,844.73 |
| Jun 22, 2023 | IBRD-92310 | Loan Disb | 1,334,902.00 |
| Dec 26, 2023 | IBRD-92310 | Loan Disb | 1,240,091.90 |
| Aug 15, 2024 | IBRD-92310 | Int Charges | 432.14 |
| Aug 21, 2023 | IBRD-92310 | Int Charges | 2,096.87 |
| Aug 21, 2023 | IBRD-92310 | Int Charges | 3,225.78 |
| Aug 21, 2023 | IBRD-92310 | Int Charges | 55,581.00 |
| Feb 15, 2023 | IBRD-92310 | Int Charges | 2,507.07 |
| Feb 15, 2023 | IBRD-92310 | Int Charges | 45,091.23 |
| Feb 15, 2023 | IBRD-92310 | Int Charges | 3,227.60 |
| Jan 28, 2022 | IBRD-92310 | Loan Disb | 1,987,227.00 |
| Aug 15, 2022 | IBRD-92310 | Int Charges | 810.77 |
| Aug 15, 2022 | IBRD-92310 | Int Charges | 12,801.15 |
| Oct 6, 2021 | IBRD-92310 | Loan Disb | 12,500.00 |
| Oct 6, 2021 | IBRD-92310 | Fee Charges | 12,500.00 |
| Feb 16, 2024 | IBRD-90980 | Int Charges | 217,152.84 |
| Jan 18, 2022 | IBRD-90980 | Loan Disb | 808,516.80 |
| Aug 15, 2022 | IBRD-90980 | Int Charges | 155.06 |
| Aug 15, 2022 | IBRD-90980 | Int Charges | 763.06 |
| Feb 15, 2021 | IBRD-90980 | Int Charges | 36,271.53 |
| Aug 15, 2020 | IBRD-90980 | Int Charges | 112.80 |
| Feb 16, 2024 | IBRD-92310 | Int Charges | 107,422.94 |
| Feb 16, 2024 | IBRD-92310 | Int Charges | 1,665.28 |
| Feb 16, 2024 | IBRD-92310 | Int Charges | 11,627.47 |
| Feb 15, 2024 | IBRD-92310 | Int Charges | 493.73 |
Ratings
IMPLEMENTATION RATINGS
| Name | Review | Date |
|---|---|---|
| Procurement | Satisfactory | 2024-12-24 |
| Monitoring and Evaluation | Moderately Satisfactory | 2024-12-24 |
| Overall Implementation Progress (IP) | Moderately Satisfactory | 2024-12-24 |
| Financial Management | Moderately Satisfactory | 2024-12-24 |
| Progress towards achievement of PDO | Satisfactory | 2024-12-24 |
| Project Management | Moderately Satisfactory | 2024-12-24 |
COMPLETION RATINGS
No data available.
INDEPENDENT EVALUATION RATINGS
No data available.
Results Framework
PROJECT DEVELOPMENT OBJECTIVE INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
Number of targeted hospitals and health centers with COVID-19 triage capacity Value 1.00 14.00 15.00 Date March 31, 2020 December 31, 2023 March 31, 2024 Comment Percentage of the population vaccinated, as defined in national plan Value 0.00 36.90 37.00 Date March 18, 2021 December 31, 2023 March 31, 2024 Comment Number of health emergency preparedness and response simulation exercises completed Value 0.00 2.00 2.00 Date April 30, 2021 December 31, 2023 March 31, 2024 Comment Percentage of females vaccinated, as defined in national plan Value 0.00 40.30 40.00 Date March 18, 2021 December 31, 2023 March 31, 2024 Comment
INTERMEDIATE RESULTS INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
Number of health staff trained in COVID-19 infection prevention and control per MOH-approved protocols Value 1154.00 9304.00 8671.00 Date March 31, 2020 December 31, 2023 March 31, 2024 Comment National Health Emergency Response Operations Plan For All Hazards developed and not older than 24 months Value No Yes Yes Date March 18, 2021 December 31, 2023 March 31, 2024 Comment Finalized and budgeted micro-plans for health emergency rapid procurements Value No No Yes Date March 18, 2021 December 31, 2023 March 31, 2024 Comment Percentage of grievances addressed within the stipulated timeframe in the Stakeholder Engagement Plan Value 0.00 84.00 70.00 Date March 31, 2020 December 31, 2023 March 31, 2024 Comment Number of staff trained in surveillance and advanced data analytics, interpretation and use Value 0.00 36.00 40.00 Date March 18, 2021 December 31, 2023 March 31, 2024 Comment Number of COVID-19 tests conducted by the designated in-country laboratory Value 0.00 590886.00 590000.00 Date March 31, 2020 December 31, 2023 March 31, 2024 Comment Proportion of targeted border control sites with trained teams and the necessary means of control, isolation and transport to isolation and care sites Value 12.00 100.00 100.00 Date March 31, 2020 December 31, 2023 March 31, 2024 Comment Number of health staff trained in COVID-19 vaccination deployment per MOH-approved protocols Value 0.00 4225.00 4225.00 Date March 18, 2021 December 31, 2023 March 31, 2024 Comment Number of targeted hospitals and health centers with at least 1 frontline worker who has been trained on how to provide quality andcomprehensive care to GBV survivors Value 0.00 14.00 15.00 Date March 18, 2021 December 31, 2023 March 31, 2024 Comment Number of female health staff trained in COVID-19 infection prevention and control per MOH-approved protocols Value 920.00 7080.00 6712.00 Date March 18, 2021 December 31, 2023 March 31, 2024 Comment Number of female staff trained in surveillance and advanced data analytics, interpretation and use Value 0.00 17.00 25.00 Date March 25, 2021 December 31, 2023 March 31, 2024 Comment Number of female health staff trained in COVID-19 vaccination deployment per MOH-approved protocols Value 0.00 2631.00 2631.00 Date March 18, 2021 September 30, 2023 March 31, 2024 Comment